← Eichor
Study identifier: NCT05562557 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

Condition: Substance Use · Child Abuse · Child Neglect  ·  Sponsor: Montefiore Medical Center

PhaseNA
Planned participants240
Who can joinMale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Montefiore will engage fathers in families at risk of substance misuse in the Bronx and neighboring communities. Families will be referred from Bronx and neighboring community-based child welfare systems, substance use disorder (SUD) treatment providers, and medical providers if identified at risk of substance use concerns and will be randomly assigned to receive services as usual as part of the comparison group, or to receive enhanced services as part of the program group. Enhanced services include: (1) Motivational Enhancement; (2) referral to Healthy, Empowered, Resilient, and Open (HERO) Dads fatherhood engagement program; (3) Contingency Management; and (4) Case Management.

This description comes directly from the study's public registry record.

Talk to the study team

Anita Jose, PhD  ·  718-401-5060  ·  ajose@montefiore.org

Alessandra de Marchena, LCSW  ·  718-401-5060  ·  allongo@montefiore.org

Always discuss trial participation with your own doctor first.

Locations (1)

Montefiore Medical CenterThe Bronx, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05562557